Track topics on Twitter Track topics that are important to you
In the pharmaceutical industry, many products have been launched using well-established processes. But if new products are to reach greater heights, these processes must be improved. What’s needed is the boost that only smart, interconnected technologies and real-time analyses can deliver. That’s the governing philosophy behind Rentschler Biopharma building out its first U.S. site, which will be an “innovation center” focused on designer biologics.
Original Article: German CDMO Forms “Smart” U.S. SubsidiaryNEXT ARTICLE
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...